NCT03067246

Brief Summary

A study comparing two second generation supraglottic Airway devices, the VBM intubating laryngeal tube and the I-Gel.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 16, 2016

Completed
16 days until next milestone

Study Start

First participant enrolled

January 1, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 1, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 5, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 5, 2019

Completed
Last Updated

July 31, 2019

Status Verified

February 1, 2018

Enrollment Period

2.4 years

First QC Date

December 16, 2016

Last Update Submit

July 30, 2019

Conditions

Keywords

Supraglottic deviceFibre optic scopeEndotracheal intubation

Outcome Measures

Primary Outcomes (1)

  • Time in seconds required for placement of supraglottic device

    Time from device first enters mouth and appearance of end-tidal CO2

    Through study completion, an average of 30 minutes

Secondary Outcomes (2)

  • Seal pressure measured in cmH2O

    Through study completion, an average of 30 minutes

  • Successful endotracheal intubation through the supraglottic airway, end tidal carbon dioxide monitoring in kilopascals

    Through study completion, an average of 30minutes

Study Arms (2)

VBM Intubating Laryngeal Tube

ACTIVE COMPARATOR

Device: VBM Intubating Laryngeal Tube Intervention: VBM Intubating Laryngeal Tube insertion, seal pressure, endotracheal intubation

Device: VBM Intubating Laryngeal Tube

I-Gel

ACTIVE COMPARATOR

Device: I-Gel Intervention: I-Gel insertion, seal pressure, endotracheal intubation

Device: I-Gel

Interventions

The position of the VBM Intubating Laryngeal Tube will be assessed using a fibreoptic scope following balloon inflation of the cuff. Seal pressure will be assessed with the presence of the inflated cuff. Endotracheal intubation through the intubating laryngeal tube with a size 7 VBM reinforced tube will be assessed using a fiberoptic scope.

VBM Intubating Laryngeal Tube
I-GelDEVICE

The position of the I-Gel will be assessed using a fibreoptic scope. The seal pressure will be assessed with the specified design of the I-Gel in the absence of a cuff. Endotracheal intubation through the I-Gel with a size 7 reinforced endotracheal tube will be assessed using a fiberoptic scope.

I-Gel

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Any patient between the age of 18 - 70
  • Any patient having the capacity to consent
  • Any patient requiring general anaesthesia but not endotracheal intubation immediately after induction of anaesthesia.

You may not qualify if:

  • Patient refusal
  • Patients involved in another research project
  • Patients who require endotracheal intubation immediately after induction of anaesthesia
  • Patients who are systemically unwell/unstable
  • Patients at risk of aspiration

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guy's and St Thomas NHS Foundation Trust

London, SE1 9RT, United Kingdom

Location

Related Publications (1)

  • Miller DM. Third generation supraglottic airways: is a new classification needed? Br J Anaesth. 2015 Oct;115(4):634-5. doi: 10.1093/bja/aev310. No abstract available.

Related Links

Study Officials

  • Imran Ahmad, MBBS

    Guy's and St Thomas' NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 16, 2016

First Posted

March 1, 2017

Study Start

January 1, 2017

Primary Completion

June 5, 2019

Study Completion

June 5, 2019

Last Updated

July 31, 2019

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share

No individual participant data will be made available

Locations